Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back

Rita T. Lawlor

ARC-Net and Department of Engineering for Innovative Medicine, University of Verona, Italy, Veneto, Italy

Rita T. Lawlor is a Health Research, ICT and privacy professional with 25 years’ management experience and a proven record of leading health and research innovation and delivering results. She has held Directorships and leading positions in biobanking and research organizations and has extensive international experience. Rita Lawlor is co-founder of the ARC-Net applied cancer research centre where she is vice director of the centre and runs the cancer biobank.

Rita is originally a Computer Science graduate with a doctorate in translational biomedical sciences in Oncological Pathology. More recently she was conferred with a fellow of Information Privacy from IAPP (International Association of Privacy Professionals) and is chair of the ISBER GDPR Task Force. Her current research interests are in molecular diagnostic markers and therapeutic targets and the role of cancer heterogeneity and molecular characterization of samples in the application of personalized medicine.

She for the ARGO project, part of the International Cancer Genome Consortium and is chair of its Ethics, Policy and Goverance working group.
She is vice chair of the Science Policy Committee of ISBER, International Society for Biological and Environmental Repositories (www.isber.org) and chair of the International Cancer Genome Consortium ARGO Ethics and Governance Committee (www.icgc-argo.org). She is a board member of the Italian Foundation for Pancreas diseases (FIMP). She is a member of the steering committee of BC-NET (Biobank Cohort Network of Low Middle Income Countries) network of IARC (International Association for Research on Cancer).

Presentation(s):